Cargando…

Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders

Backgrounds: Growth hormone (GH) was used for many years to increase ovarian response in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy improve early clinical outcomes, the benefit of GH usage on chance of live birth was still widely debated. This study was to deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jinliang, Wang, Ying, Chen, Lixue, Liu, Ping, Li, Rong, Qiao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990136/ https://www.ncbi.nlm.nih.gov/pubmed/32038495 http://dx.doi.org/10.3389/fendo.2020.00001

Ejemplares similares

Clinical Outcomes of Frozen-Thawed Embryos Generated From Growth Hormone Stimulation in Expected Poor Responders
por: Zhu, Jinliang, et al.
Publicado: (2021)

DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis
por: Keane, Kevin N., et al.
Publicado: (2018)

Cumulative Live Birth Rate and Cost-Effectiveness Analysis of Gonadotropin Releasing Hormone-Antagonist Protocol and Multiple Minimal Ovarian Stimulation in Poor Responders
por: Liu, Yuan, et al.
Publicado: (2021)

Heterogeneity Among Poor Ovarian Responders According to Bologna Criteria Results in Diverging Cumulative Live Birth Rates
por: Romito, Alessia, et al.
Publicado: (2020)

Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders
por: Errázuriz, Joaquín, et al.
Publicado: (2019)

High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients
por: Guo, Yaxin, et al.
Publicado: (2021)

Low Dose Growth Hormone Adjuvant Treatment With Ultra-Long Ovarian Stimulation Protocol in Poor Responders Showed Non-inferior Pregnancy Outcome Compared With Normal Responders
por: Lee, Yi-Xuan, et al.
Publicado: (2019)

Season and temperature do not affect cumulative live birth rate and time to live birth in in vitro fertilization
por: Du, Mingze, et al.
Publicado: (2023)

Age-specific anti-Mullerian hormone (AMH) levels poorly affects cumulative live birth rate after intra-uterine insemination
por: Moreau, Jessika, et al.
Publicado: (2019)

Natural cycle increases the live-birth rate compared with hormone replacement treatment for frozen-thawed single euploid blastocyst transfer
por: Li, Xiaofang, et al.
Publicado: (2022)

Progesterone Intramuscularly or Vaginally Administration May Not Change Live Birth Rate or Neonatal Outcomes in Artificial Frozen-Thawed Embryo Transfer Cycles
por: Liu, Yuan, et al.
Publicado: (2020)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
por: Chen, Qiuju, et al.
Publicado: (2019)

Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve
por: Hart, Roger J.
Publicado: (2019)

Live Birth Rate in Patients With Premature Ovarian Insufficiency During Long-Term Follow-Up Under Hormone Replacement With or Without Ovarian Stimulation
por: Ishizuka, Bunpei, et al.
Publicado: (2021)

Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations
por: Zhou, Ruiqiong, et al.
Publicado: (2023)

Impact of thyroid-stimulating hormone levels after controlled ovarian hyperstimulation on in vitro fertilization/intracytoplasmic sperm injection outcomes in women with fresh embryo transfer: a prospective cohort study
por: Huang, Ning, et al.
Publicado: (2023)

Stress-associated weight gain, fibromyalgia symptoms, cardiometabolic markers, and human growth hormone suppression respond to an amino acid supplement blend: Results of a prospective, cohort study
por: Pekarovics, Susan, et al.
Publicado: (2023)

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos
por: Takeuchi, Kazuhiro, et al.
Publicado: (2023)

The effect of the pooling method on the live birth rate in poor ovarian responders according to the Bologna criteria
por: Çelik, Serdar, et al.
Publicado: (2018)

Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment
por: Chai, Joyce, et al.
Publicado: (2015)

Criteria for First-Year Growth Response to Growth Hormone Treatment in Prepubertal Children With Growth Hormone Deficiency: Do They Predict Poor Adult Height Outcome?
por: Straetemans, Saartje, et al.
Publicado: (2019)

Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles
por: Mai, Zhuoyao, et al.
Publicado: (2021)

Growth hormone supplementation ameliorates blastocyst euploidy rates and improves pregnancy outcomes in women undergoing preimplantation genetic testing for aneuploidy cycles
por: Guo, Qingqing, et al.
Publicado: (2023)

Correction: Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment
por: Chai, Joyce, et al.
Publicado: (2015)

Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification
por: Grisendi, Valentina, et al.
Publicado: (2019)

What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?
por: Blumenfeld, Zeev
Publicado: (2020)

Effects of follicular output rate on cumulative clinical pregnancy rate and cumulative live birth rate in PCOS patients with different characteristics
por: Jiang, Rulan, et al.
Publicado: (2022)

Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study
por: Chen, Minghui, et al.
Publicado: (2020)

Analysis of IVF/ICSI Outcomes in Endometriosis Patients With Recurrent Implantation Failure: Influence on Cumulative Live Birth Rate
por: Zhong, Chenyi, et al.
Publicado: (2021)

THU194 Growth Pattern And Related Predictors Of Gonadotropin-releasing Hormone Analog Treatment In Girls With Precocious Puberty
por: Ouyang, Lixue, et al.
Publicado: (2023)

Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study
por: Li, Zhen, et al.
Publicado: (2022)

High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndrome
por: Su, Nianjun, et al.
Publicado: (2023)

Development and validation of a live birth prediction model for expected poor ovarian response patients during IVF/ICSI
por: Gong, Xiaoyun, et al.
Publicado: (2023)

The earlier the initiation of gonadotropin in poor responders in luteal phase stimulation protocols, the better
por: Huang, Jia, et al.
Publicado: (2022)

The Optimal Number of Oocytes Retrieved From PCOS Patients Receiving IVF to Obtain Associated With Maximum Cumulative Live Birth Rate and Live Birth After Fresh Embryo Transfer
por: Jia, Rui, et al.
Publicado: (2022)

Impact of Female Obesity on Cumulative Live Birth Rates in the First Complete Ovarian Stimulation Cycle
por: Ding, Wen, et al.
Publicado: (2019)

Mitochondrial DNA Content May Not Be a Reliable Screening Biomarker for Live Birth After Single Euploid Blastocyst Transfer
por: Zhou, Xuanyou, et al.
Publicado: (2021)

Is a Two-Year Growth Response to Growth Hormone Treatment a Better Predictor of Poor Adult Height Outcome Than a First-Year Growth Response in Prepubertal Children With Growth Hormone Deficiency?
por: Straetemans, Saartje, et al.
Publicado: (2021)

The Potential Role of Growth Hormone on the Endometrium in Assisted Reproductive Technology
por: Liu, Fen-Ting, et al.
Publicado: (2020)

A Premature Rise of Luteinizing Hormone Is Associated With a Reduced Cumulative Live Birth Rate in Patients ≥37 Years Old Undergoing GnRH Antagonist In Vitro Fertilization Cycles
por: Gao, Fumei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n2hmat5jgvtedr9c3aefsabn53